Cargando…
Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a chronic proliferative disease showing stromal-dominant proliferation. However, the detailed proliferation mechanism has remained unclear. Although aging and androgen have been reported as definitive risk factors for BPH, recent studies have focused on the invo...
Autores principales: | Hata, Junya, Harigane, Yuki, Matsuoka, Kanako, Akaihata, Hidenori, Yaginuma, Kei, Meguro, Satoru, Hoshi, Seiji, Sato, Yuichi, Ogawa, Soichiro, Uemura, Motohide, Kojima, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380833/ https://www.ncbi.nlm.nih.gov/pubmed/37511400 http://dx.doi.org/10.3390/ijms241411634 |
Ejemplares similares
-
PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues
por: Hoshi, Seiji, et al.
Publicado: (2023) -
Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia
por: Hata, Junya, et al.
Publicado: (2019) -
Role of puboperinealis and rectourethralis muscles as a urethral support system to maintain urinary continence after robot-assisted radical prostatectomy
por: Kataoka, Masao, et al.
Publicado: (2023) -
Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat
por: Akaihata, Hidenori, et al.
Publicado: (2023) -
SMARCB1‐deficient basal cell carcinoma of the prostate controlled using radiation therapy
por: Makabe, Shunta, et al.
Publicado: (2023)